Anthrax Post-Exposure Drugs Need Extensive Marketing History – Draft Guidance

Drugs should have broad postmarketing experience before sponsors pursue an indication for post-exposure anthrax, a draft guidance from FDA's Center for Drug Evaluation & Research states